lifestyle.longislandreport.org

Author: JAZZ PHARMACEUTICALS INC

Jazz Pharmaceuticals Appoints Thomas Riga as Chief Business Officer

January 8, 2026
Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA Including More Than Two Years Median Overall Survival Benefit

January 6, 2026
Jazz Pharmaceuticals to Participate in Upcoming Investor Events

December 30, 2025